194 related articles for article (PubMed ID: 7269003)
1. Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.
Labeeuw M; Gerbaulet C; Pozet N; Zech P; Traeger J
Urol Res; 1981; 9(4):163-8. PubMed ID: 7269003
[TBL] [Abstract][Full Text] [Related]
2. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
Worcester EM; Coe FL; Evan AP; Parks JH
BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
[TBL] [Abstract][Full Text] [Related]
3. Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine.
Martins MC; Meyers AA; Whalley NA; Rodgers AL
J Urol; 2002 Jan; 167(1):317-21. PubMed ID: 11743349
[TBL] [Abstract][Full Text] [Related]
4. Durability of the medical management of cystinuria.
Pietrow P; Auge BK; Weizer AZ; Delvecchio FC; Silverstein AD; Mathias B; Albala DM; Preminger GM
J Urol; 2003 Jan; 169(1):68-70. PubMed ID: 12478105
[TBL] [Abstract][Full Text] [Related]
5. Cystine crystal volume determination: a useful tool in the management of cystinuric patients.
Daudon M; Cohen-Solal F; Barbey F; Gagnadoux MF; Knebelmann B; Jungers P
Urol Res; 2003 Jul; 31(3):207-11. PubMed ID: 12748836
[TBL] [Abstract][Full Text] [Related]
6. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.
Modersitzki F; Pizzi L; Grasso M; Goldfarb DS
Urolithiasis; 2014 Feb; 42(1):53-60. PubMed ID: 24253538
[TBL] [Abstract][Full Text] [Related]
8. Cystine Stone Formers Have Impaired Health-Related Quality of Life Compared with Noncystine Stone Formers: A Case-Referent Study Piloting the Wisconsin Stone Quality of Life Questionnaire Among Patients with Cystine Stones.
Streeper NM; Wertheim ML; Nakada SY; Penniston KL
J Endourol; 2017 Apr; 31(S1):S48-S53. PubMed ID: 27717296
[TBL] [Abstract][Full Text] [Related]
9. Cystine stones: the impact of new treatment.
Martin X; Salas M; Labeeuw M; Pozet N; Gelet A; Dubernard JM
Br J Urol; 1991 Sep; 68(3):234-9. PubMed ID: 1913062
[TBL] [Abstract][Full Text] [Related]
10. Can the Presence of Crystalluria Predict Stone Formation in Patients with Cystinuria?
Wong KA; Pardy C; Pillay S; Athanasiou T; Rottenberg G; Bultitude M; Chandra A; Thomas K
J Endourol; 2016 May; 30(5):609-14. PubMed ID: 26781171
[TBL] [Abstract][Full Text] [Related]
11. Cystine urinary lithiasis in Thailand: a report of five cases.
Chaimuangraj S; Jamavan K; Mokkhavesa C; Timvipak C; Junvimalaung N; Stitchantrakul W; Kochakarn W; Gojaseni P
J Med Assoc Thai; 2003 Jun; 86(6):573-8. PubMed ID: 12924806
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of crystalluria study].
Daudon M; Jungers P; Lacour B
Ann Biol Clin (Paris); 2004; 62(4):379-93. PubMed ID: 15297232
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].
Asanuma H; Nakai H; Takeda M; Shishido S; Kawamura T; Nagakura K; Yamafuji M
Nihon Hinyokika Gakkai Zasshi; 1998 Sep; 89(9):758-65. PubMed ID: 9796255
[TBL] [Abstract][Full Text] [Related]
14. Do Urinary Cystine Parameters Predict Clinical Stone Activity?
Friedlander JI; Antonelli JA; Canvasser NE; Morgan MSC; Mollengarden D; Best S; Pearle MS
J Urol; 2018 Feb; 199(2):495-499. PubMed ID: 28916274
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous cystinuria and calcium oxalate urolithiasis.
Resnick MI; Goodman HO; Boyce WH
J Urol; 1979 Jul; 122(1):52-4. PubMed ID: 458988
[TBL] [Abstract][Full Text] [Related]
16. Cystine calculi: challenging group of stones.
Ahmed K; Dasgupta P; Khan MS
Postgrad Med J; 2006 Dec; 82(974):799-801. PubMed ID: 17148700
[TBL] [Abstract][Full Text] [Related]
17. Cystine stones: a single tertiary center experience.
Sfoungaristos S; Hakim R; Katz R; Gofrit ON; Landau EH; Yutkin V; Pode D; Duvdevani M
J Endourol; 2015 Mar; 29(3):362-6. PubMed ID: 25133928
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi.
Daudon M; Jungers P
Nephron Physiol; 2004; 98(2):p31-6. PubMed ID: 15499212
[TBL] [Abstract][Full Text] [Related]
19. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
[TBL] [Abstract][Full Text] [Related]
20. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
